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Abstract
The ATP-induced oscillatory changes in cytosolic Ca2 concentration ([Ca2]i) were analysed in HSY cells, a salivary
ductal cell line from human parotid, using a fluorescence ratio imaging system. At concentrations higher than 1 WM, ATP
caused sinusoidal [Ca2]i oscillations due to the periodic release and reuptake of Ca2 by intracellular Ca2 stores. The
phorbol ester 4L-phorbol 12,13-dibutyrate (PDBu) changed the [Ca2]i oscillations to a single spike. The inhibitory effect of
PDBu on the [Ca2]i signals was reversed by protein kinase C (PKC) inhibitors such as staurosporine and chelerythrine
chloride. However, preincubation of the cells with the PKC inhibitors did not affect the pattern of the ATP-induced [Ca2]i
oscillations. The desensitization of the [Ca2]i response observed during prolonged stimulation with ATP was also not
prevented by the PKC inhibitors. Incubation of HSY cells with the sulphydryl reagent thimerosal, which enhances the
sensitivity of inositol 1,4,5-trisphosphate (IP3) receptors, caused repetitive Ca2 release from intracellular Ca2 stores
resulting in baseline spikes of [Ca2]i. The thimerosal-induced [Ca2]i oscillations did not change in the presence of PDBu
and the phospholipase C inhibitor U73122. Thus, we could not provide evidence that negative feedback by PKC plays a
central role in the regulation of ATP-induced [Ca2]i oscillations. These results suggest that the [Ca2]i oscillations, at least
the baseline spikes, in HSY cells can be generated without stimulating the formation of IP3. ß 2001 Elsevier Science B.V.
All rights reserved.
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1. Introduction
In a variety of cell types, stimulation of surface
membrane receptors linked to the phosphoinositide
signalling pathway often results in oscillatory
changes in cytosolic free Ca2 concentration
([Ca2]i). Although di¡erent models have been pro-
posed to explain the generation of such [Ca2]i oscil-
lations [1^4], the molecular mechanisms are not fully
established. Based on the ¢ndings that activators or
inhibitors of PKC prevent or modulate [Ca2]i oscil-
lations [5^8], one of the models postulates that pro-
tein kinase C (PKC) plays the key role in the mech-
anisms regulating [Ca2]i oscillations. In this model,
the [Ca2]i oscillations re£ect an oscillatory forma-
tion of inositol 1,4,5-trisphosphate (IP3) resulting
from negative feedback by PKC on IP3 formation.
However, the involvement of PKC in [Ca2]i oscilla-
tions is still the subject of debate. In several models,
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it has been suggested that the feedback by PKC and
the £uctuations of IP3 are not essential for the reg-
ulation of [Ca2]i oscillations. There the Ca2-in-
duced Ca2 release and the positive and negative
feedback e¡ects of Ca2 itself on IP3 receptor activ-
ity are thought to play an important role in the gen-
eration of [Ca2]i oscillations [9^13].
The HSY cells, a salivary ductal cell line from
human parotid, have been used as a model system
for the study of intracellular Ca2 signalling events
[14^17]. Tanimura and Turner [15] have found that
application of IP3 to saponin-permeabilized HSY
cells can cause repetitive release and reuptake of
Ca2 by intracellular stores, supporting the model
that the [Ca2]i oscillations arise directly from the
feedback e¡ects of Ca2 itself on IP3 receptor activ-
ity.
ATP is a potent agonist to mobilize Ca2 from
intracellular stores by the activation of phosphoino-
sitide hydrolysis in salivary ductal cell lines [18]. To
assess the involvement of PKC in ATP-induced
[Ca2]i oscillations, the present study has examined
the e¡ects of PKC modulators on the [Ca2]i oscil-
lations in HSY cells. Further, we have analysed the
changes in [Ca2]i during treatment with the sul-
phydryl reagent thimerosal, which can sensitize cells
to basal IP3 levels [19,20]. As the sulphydryl reagents
are able to induce a Ca2 release from IP3 receptor
channels without stimulating IP3 formation, analysis
of the thimerosal-induced Ca2 release may provide
information when considering the mechanism regu-
lating [Ca2]i oscillations in HSY cells.
2. Materials and methods
2.1. Materials
Fura 2-acetoxymethyl ester (fura 2-AM) was pur-
chased from Dojin Laboratories (Kumamoto, Ja-
pan). The ATP, chelerythrine chloride and 4K-phor-
bol 12,13-didecanoate (4K-PDD) were purchased
from Sigma (St. Louis, MO, USA). Thimerosal was
from ICN Biomedicals (Aurora, CO, USA). Stauro-
sporine, thapsigargin, 4L-phorbol 12,13-dibutyrate
(PDBu), U73122, and U73343 were from Wako
Pure Chemical (Osaka, Japan). K-252a was from
Kyowa Medex (Tokyo, Japan).
2.2. Cell culture
HSY cells were grown as described elsewhere [14]
in a 50:50 mixture of Dulbecco’s modi¢ed Eagle’s
medium and Ham’s F-12 medium supplemented
with 10% newborn calf serum, 2 mM glutamine,
100 Wg/ml penicillin and 100 Wg/ml streptomycin.
For the £uorescence experiments, the HSY cells
were transferred from plastic culture dishes to
13U13 mm sample chambers consisting of cylinders
glued to round glass coverslips, and allowed to grow
for a further 2^4 days before use.
2.3. [Ca2+]i measurement
HSY cells in sample chambers were washed with
HBSS-H (Hanks’ balanced salt solution bu¡ered
with 20 mM HEPES-NaOH (pH 7.4)) and then in-
cubated with 2 WM fura 2-AM for 40^60 min at
room temperature. After loading with fura 2, the
chamber was rinsed twice with HBSS-H and
mounted on the stage of a Nikon Diaphot inverted
microscope (Nikon, Tokyo, Japan) equipped with a
Nikon CF Fluor 20U objective. Excitation wave-
lengths were set at 340 and 380 nm. Emitted light
was passed through a 400 nm dichroic mirror, ¢l-
tered at 520 nm and collected by a cooled CCD
camera (Hamamatsu Photonics, Shizuoka, Japan).
The £uorescence ratio images were digitized at 5 s
intervals and stored in an ARGUS HiSCA imaging
system (Hamamatsu Photonics). The changes in
[Ca2]i were shown as the 340/380 nm £uorescence
ratio.
The vacuum line was placed in the sample cham-
ber and adjusted so that the volume of the solution
was maintained at approx. 50 Wl. Solution changes
were accomplished by the addition of 500 Wl of fresh
solution to the chamber. All experiments were car-
ried out at room temperature.
3. Results
3.1. Characterization of ATP-induced [Ca2+]i
oscillations
HSY cells were intermittently exposed to succes-
sively greater concentrations of ATP. Fig. 1A shows
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typical changes in [Ca2]i analysed by single-cell
Ca2 recording. In most cells, stimulation with low
concentrations of ATP (9 0.5 WM) caused only a
single spike in [Ca2]i which did not result in oscil-
latory responses. At concentrations higher than 1 WM,
ATP induced sinusoidal oscillatory changes in
[Ca2]i in 118 out of 131 cells examined. The number
of oscillatory peaks observed during the 100 s stim-
ulation increased in a concentration-dependent man-
ner, and stimulation with a supramaximal concentra-
tion (100 WM) of ATP resulted in a plateau-like
increase in [Ca2]i with little or no oscillations. Re-
moval of extracellular Ca2 by switching to Ca2-
free medium containing 0.2 mM EGTA did not alter
the oscillatory pattern of [Ca2]i (Fig. 1B), indicating
that the ATP-induced [Ca2]i oscillations are primar-
ily dependent on the periodic release and reuptake of
Ca2 at intracellular Ca2 stores.
Fig. 2 shows a typical oscillatory pattern in [Ca2]i
in a single HSY cell exposed continuously to 10 WM
ATP. The ATP-induced oscillatory response was
gradually attenuated during the stimulation and
ceased within 10 min after stimulation. This cessation
cannot be attributed to depletion of intracellular
Ca2 stores, since subsequent addition of 0.5 WM
thapsigargin (TG), an inhibitor of the endoplasmic
reticulum Ca2 pump, caused a further increase in
[Ca2]i (Fig. 2). Prolonged stimulation with lower
concentrations (0.5 or 1 WM) of ATP resulted in
only a single or a few spikes of [Ca2]i (data not
shown).
3.2. E¡ects of PKC activators and inhibitors on
ATP-induced [Ca2+]i oscillations
In the presence of 100 nM PDBu, a phorbol ester
which activates PKC, stimulation with 5 WM ATP
produced only a single spike of [Ca2]i in 73 of 89
cells with no oscillations observed (Fig. 3A). Similar
single spikes of [Ca2]i following stimulation with
ATP were also observed in the presence of another
phorbol ester, PMA (50 nM), whereas the inactive
phorbol ester 4K-PDD (100 nM) had no e¡ect on the
ATP-induced [Ca2]i oscillations (data not shown).
Fig. 1. ATP-induced [Ca2]i oscillations in single HSY cells.
The [Ca2]i was measured in single HSY cells loaded with fura
2 and is shown as the £uorescence ratio of 340/380 nm. ATP
was applied during the period indicated by the solid horizontal
bars. (A) Changes in [Ca2]i recorded from a single cell exposed
intermittently to increasing concentrations of ATP. The re-
sponse shown is representative of more than 100 cells. (B)
Changes in [Ca2]i in a single cell exposed repeatedly to 10 WM
ATP in Ca2-free and Ca2-containing external solution. The
external solution was exchanged to Ca2-free solution contain-
ing 0.2 mM EGTA as indicated by the dotted line.
Fig. 2. Desensitization of the [Ca2]i response during prolonged
ATP stimulation. Cells were exposed to 10 WM ATP and subse-
quently to 0.5 WM thapsigargin (TG) during the period indi-
cated by the horizontal bars.
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In order to show that the inhibition of the ATP-
induced [Ca2]i signal by phorbol esters was due to
activation of PKC, we examined if PKC inhibitors
can reverse the inhibitory action of PDBu. When the
cells were exposed to 5 WM ATP in the presence of
both 100 nM PDBu and 200 nM staurosporine, a
potent PKC inhibitor, oscillatory changes in [Ca2]i
occurred in 92 out of 116 cells examined (Fig. 3B).
Chelerythrine chloride (10 WM), a more speci¢c PKC
inhibitor [21], also reversed the inhibitory e¡ect of
PDBu on the ATP-induced [Ca2]i signal in 22 out
of 39 cells (data not shown), although chelerythrine
chloride was not so potent as staurosporine. These
results suggest that the phorbol esters suppressed the
[Ca2]i signal through activation of PKC. When
staurosporine was added after exposure to both
ATP and PDBu, the inhibitory action of PDBu
was not clearly reversed by staurosporine (data not
shown).
In several cell types, it has been reported that
treatment with PKC inhibitors changes the agonist-
mediated oscillations in [Ca2]i to a sustained, non-
oscillatory increase in [Ca2]i or delays the rate of
the falling phase in the Ca2 spike [5,7,8]. To inves-
tigate this possibility in HSY cells, the ATP-induced
changes in [Ca2]i were monitored in the presence of
PKC inhibitors. Preincubation for 5 min with 200
nM staurosporine, which can reverse the e¡ect of
PDBu, did not a¡ect the pattern of [Ca2]i oscilla-
tions induced by 5 WM ATP, and the desensitization
of [Ca2]i response was not prevented (Fig. 4A).
Even when the preincubation period was extended
up to 30 min, staurosporine failed to change the
Fig. 3. E¡ect of the phorbol ester PDBu on ATP-induced
[Ca2]i oscillations in the absence (A) and presence (B) of stau-
rosporine. (A) Changes in [Ca2]i in a single cell exposed simul-
taneously to 5 WM ATP and 100 nM PDBu. (B) Changes in
[Ca2]i in a single cell exposed simultaneously to 5 WM ATP
and 100 nM PDBu in the presence of 200 nM staurosporine
(Stauro). The agents were applied during the period indicated
by the horizontal bars.
Fig. 4. ATP-induced [Ca2]i oscillations in the presence of PKC
inhibitors. Cells were stimulated with 5 WM ATP in the pres-
ence of 200 nM staurosporine (Stauro) (A) or 10 WM cheler-
ythrine chloride (Che-Cl) (B). ATP and the PKC inhibitors
were applied during the period indicated by the horizontal bars.
BBAMCR 14753 21-5-01
Y. Tojyo et al. / Biochimica et Biophysica Acta 1539 (2001) 114^121 117
oscillatory patterns (data not shown). Chelerythrine
chloride (10 WM) (Fig. 4B) and another PKC inhib-
itor, K252a (data not shown), also had no e¡ect on
the ATP-induced oscillations in [Ca2]i.
3.3. Thimerosal-induced [Ca2+]i oscillations
Sulphydryl reagents including thimerosal have
been shown to open the IP3 receptor channels with-
out activation of phosphoinositide hydrolysis result-
ing in formation of IP3 [19,20,22,23]. The IP3 recep-
tor channels are thought to be sensitized to basal IP3
levels in the presence of thimerosal. If the thimerosal-
induced Ca2 release exhibits oscillatory changes in
[Ca2]i, it would provide further evidence that
[Ca2]i oscillations may be induced without £uctua-
tions of IP3 and PKC.
At concentrations v 200 WM, thimerosal caused
repetitive [Ca2]i responses following a long latency
(5^10 min) before the onset of the rise in [Ca2]i (Fig.
5). In the presence of extracellular Ca2, the changes
in [Ca2]i were accompanied with a progressive in-
crease in basal [Ca2]i (Fig. 5A), probably resulting
from the inhibitory e¡ect of thimerosal on the plas-
ma membrane Ca2 pumps [19]. To remove the in-
creases in the basal [Ca2]i, the thimerosal-induced
Ca2 release was monitored in the absence of extra-
cellular Ca2.
Incubation of the cells with 250 WM thimerosal
Fig. 5. Thimerosal-induced [Ca2]i oscillations in single HSY
cells. (A) Changes in [Ca2]i in a single cell exposed to 250 WM
thimerosal (TMS) in Ca2-containing solution. (B) Changes in
[Ca2]i in a single cell exposed to 250 WM TMS in Ca2-free
solution containing 0.2 mM EGTA. TMS was applied during
the period indicated by the horizontal bars.
Fig. 6. E¡ects of PDBu and U73122 on thimerosal-induced
[Ca2]i oscillations in single HSY cells. The recordings were
made in Ca2-free solution containing 0.2 mM EGTA. (A) In
the presence of 100 nM PDBu, cells were stimulated with 5 WM
ATP and then exposed to 500 WM thimerosal (TMS). (B) In
the presence of 20 WM U73122, cells were stimulated with 5 WM
ATP and then exposed to 500 WM TMS. The agents were ap-
plied during the period indicated by the horizontal bars.
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caused oscillatory changes in [Ca2]i in 118 out of
158 cells and with 500 WM thimerosal in 192 out of
195 cells. Fig. 5B shows a typical pattern of [Ca2]i
oscillations in a single HSY cell treated with 250 WM
thimerosal in Ca2-free medium. Incubation with 0.5
WM TG, which leads to the leakage of Ca2 from
intracellular stores [24], induced a noticeable increase
in [Ca2]i in the absence of extracellular Ca2, but
the response did not result in oscillatory changes
(data not shown). To show that the thimerosal-in-
duced [Ca2]i response is independent of PKC activ-
ity, the e¡ect of the PKC activator PDBu on the
thimerosal-induced oscillations was examined. Prein-
cubation with 100 nM PDBu did not inhibit the os-
cillatory changes of [Ca2]i, while stimulation with
ATP resulted in only a single spike in the presence
of PDBu (Fig. 6A). To con¢rm that the thimerosal-
induced Ca2 release does not require activation of
phosphoinositide hydrolysis, the e¡ect of U73122, a
potent inhibitor of phospholipase C, on the thimer-
osal-induced changes in [Ca2]i was examined. As
shown in Fig. 6B, preincubation with 20 WM
U73122 did not suppress the [Ca2]i responses
evoked by 500 WM thimerosal, while the ATP-in-
duced increases in [Ca2]i were completely inhibited.
The inactive analogue, U73443, had no e¡ect on the
ATP-induced [Ca2]i oscillatory response (data not
shown).
4. Discussion
The present study characterized the sinusoidal
[Ca2]i oscillations in HSY cells induced by ATP.
As removal of external Ca2 had little or no e¡ect
on the pattern of [Ca2]i oscillations, it is evident
that the [Ca2]i oscillations are due to the periodic
release and uptake of Ca2 by intracellular stores.
Incubation with U73122 completely inhibited the
[Ca2]i response to ATP, suggesting that the ATP-
induced Ca2 release in HSY cells is mediated by IP3
produced through activation of phosphoinositide hy-
drolysis. Phorbol esters changed the ATP-induced
oscillations to a single spike. As shown in a variety
of cell types [25^30], this e¡ect is probably due to an
inhibition of phosphoinositide metabolism through
activation of PKC, and a possible explanation for
the mechanism of the [Ca2]i oscillations is that neg-
ative feedback by PKC plays a direct role in the
regulation of the ATP-induced [Ca2]i oscillations.
However, pharmacological inhibition of PKC by
PKC inhibitors did not a¡ect the pattern of the
ATP-induced [Ca2]i oscillations. In addition, the
desensitization of the [Ca2]i signal during prolonged
stimulation was not prevented by the PKC inhibi-
tors. Since the inhibitory e¡ect of the phorbol ester
PDBu on the ATP-induced [Ca2]i signal was re-
versed by the PKC inhibitors, it is unlikely that the
inhibitors used here were not able to inhibit PKC.
Thus, we could not provide evidence that the nega-
tive feedback mechanism by PKC plays a central role
in the regulation of the ATP-induced [Ca2]i oscilla-
tions in HSY cells.
Activation of phosphoinositide metabolism, in ad-
dition to IP3, yields diacylglycerol which can activate
PKC, and we do not exclude the possibility that
PKC is involved in the regulation of [Ca2]i signals
in HSY cells. However, the PKC inhibitors used here
did not have any detectable e¡ect on the ATP-in-
duced [Ca2]i oscillations, while the inhibitory e¡ect
of PDBu on the [Ca2]i signal was suppressed by the
same inhibitors. This result would imply that in HSY
cells the activation of PKC by agonist stimulation is
much more moderate than the direct activation of
PKC by the phorbol esters. The role of PKC in the
control of the [Ca2]i signal in HSY cells remains to
be fully explained.
The present study has also demonstrated that thi-
merosal has the ability to induce oscillatory Ca2
release from intracellular Ca2 stores in HSY cells.
Some studies have indicated that thimerosal inhibits
the Ca2 pumps of intracellular Ca2 stores [19,31].
Treatment with TG, which results in a release of
Ca2 by inhibiting the Ca2 pumps, did not cause
[Ca2]i oscillations, and this excludes the possibility
that the mechanism causing the thimerosal-induced
oscillations is associated with inhibition of the Ca2
pumps. It may be possible that feedback regulation
of phospholipase C by the released Ca2 itself causes
periodic formation of IP3 resulting in oscillatory
changes in [Ca2]i. However, the ¢ndings that the
thimerosal-induced Ca2 release was una¡ected by
treatment with PDBu and U73122 suggest that the
activation of phosphoinositide hydrolysis is unlikely
to be linked to the action of thimerosal.
The e¡ect of thimerosal on Ca2 release suggests
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that the oscillatory changes in [Ca2]i can be gener-
ated without activation of phosphoinositide metabo-
lism. If the thimerosal- and ATP-induced [Ca2]i os-
cillations are regulated by the same mechanism, our
data support the hypothesis that the agonist-stimu-
lated [Ca2]i oscillations in HSY cells do not require
£uctuations in IP3 and PKC. However, there are
di¡erences in the property and shape of the thimer-
osal- and ATP-induced [Ca2]i oscillations. The thi-
merosal-induced [Ca2]i oscillations appeared as
baseline spikes, while the pattern of the ATP-induced
[Ca2]i oscillations was usually sinusoidal. Putney
[32] suggests that the negative feedback by PKC is
involved in the regulation of sinusoidal [Ca2]i oscil-
lations but not in the regulation of baseline spikes,
and it is not excluded that the di¡erent types of
[Ca2]i oscillations may re£ect the di¡erent mecha-
nisms.
It is established that the activity of IP3 receptors is
enhanced or inhibited by low or high concentrations
of Ca2, respectively [33,34]. Based on the biphasic
e¡ects of Ca2 itself on IP3 receptors, it has been
proposed that [Ca2]i oscillations are regulated by
the positive and negative feedback e¡ects of the re-
leased Ca2 on the activity of IP3 receptors, and this
may explain the mechanism of [Ca2]i oscillations in
HSY cells, as proposed by Tanimura and Turner
[15]. Tanimura and Turner [15] demonstrated that
exposure of saponin-permeabilized HSY cells to ex-
ternally applied IP3 results in [Ca2]i oscillations, and
this supports the positive and negative feedback
mechanism by Ca2 itself to generate the [Ca2]i os-
cillations.
Some investigators have found that intracellular
application of IP3 and stable IP3 analogues can
mimic agonist-activated [Ca2]i oscillations [35^38],
and these studies could lead to the conclusion that
oscillations in [Ca2]i occur even when the concen-
tration of IP3 is constant. In lacrimal acinar cells,
however, the intracellular application of IP3 caused
a sustained, nonoscillatory increase in [Ca2]i, while
agonist stimulation resulted in [Ca2]i oscillations [7].
In addition, a more recent study showed £uctuations
in IP3 concentration synchronous with [Ca2]i oscil-
lations by monitoring the changes in IP3 concentra-
tion using the green £uorescent protein-tagged IP3
probe [39]. Thus, there is notable disagreement in
the experimental evidence for the relationship be-
tween [Ca2]i oscillations and IP3 level. The actual
mechanisms regulating [Ca2]i oscillations may vary
in di¡erent cell types, and it is likely that more than
one mechanism can produce the characteristic pat-
terns of [Ca2]i oscillations.
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